Article
Risk stratification of indeterminate thyroid nodules by novel multigene testing: a study of Asians with a high risk of malignancy.
Molecular oncology - 1 Apr 2022
Hu Chunfang, Jing Weiwei, Chang Qing, Zhang Zhihui, Liu Zhenrong, Cao Jian, Zhao Linlin, Sun Yue, Wang Cong, Zhao Huan, Xiao Ting, Guo Huiqin
Abstract excerpt
Molecular testing of indeterminate thyroid nodules informs about the presence of point mutations, insertions/deletions, copy number variants, RNA fusions, transcript alterations and miRNA expression. American Thyroid Association (ATA) guidelines suggest molecular testing of indeterminate thyroid nodules may be considered to supplement risk of malignancy (ROM). Although these recommendations have been incorporated...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.